Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Personalised cancer vaccines take a leap forward - can Swiss pharma catch up?
For decades, the idea of a vaccine to treat cancer promised more than it delivered. That may be changing. This summer, the first successful Phase III trial of an mRNA vaccine designed around each patient's own tumour was announcedExternal link by…
Forget Treasury Bonds: This 6%-Yielding Pharma Stock Pays You to Wait for Its Pipeline
Treasury bonds offer steady, risk-free income, but Pfizer (PFE +2.59%) brings something extra to the table: a roughly 6% dividend yield and the potential for a massive turnaround. The pharmaceutical giant is expanding its portfolio beyond its…
MEPs pause vote on EU pesticides bill, as UN experts join scientists in opposition to Big Pharma
A backlash is building against an EU ‘omnibus' bill that seeks to make it easier to authorise and use pesticides across the bloc. MEPs are still yet to set a date to vote on the European Commission's proposal to extend how long pesticide…
Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying
Big drugmakers lose blockbusters to biosimilars and generics all the time. The strongest income payers keep paying anyway, because the next wave of drugs is already throwing off cash. This roster of five US-listed pharma companies is built around…
Pharmalittle: We're reading about Sanofi settling an EU antitrust probe, 'pharma bro' Shkreli, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you…
Royalty Pharma (NASDAQ:RPRX) Stock Jumps 3.3% - Here's Why
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report)'s stock price rose 3.3% on Wednesday. The stock traded as high as $58.45 and last traded at $58.4550. Approximately 722,411 shares changed hands during trading, a decline of 79% from the average…
Early gains fade by afternoon; Insurance, Pharma stocks pull indices lower
Equity benchmarks surrendered their opening gains and turned negative by midday on Wednesday, as selling in insurance and pharmaceutical stocks offset continued strength in information technology. At 1.05 pm, the Nifty 50 was trading at 22,615.25…
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month Low - Here's Why
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) reached a new 52-week low on Wednesday. The company traded as low as $20.04 and last traded at $20.19, with a volume of 989,284 shares traded. The stock had previously closed at…
Avalyn Pharma (NASDAQ:AVLN) Sets New 1-Year Low - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s stock price reached a new 52-week low during trading on Wednesday. The stock traded as low as $23.08 and last traded at $23.74, with a volume of 403,934 shares. The stock had previously closed at…
IT Stocks Gain Rs 25,029 Crore
Pharma stocks lost Rs 25,169 crore. India's information technology (IT) stocks added Rs 25,029 crore in market value on Wednesday, October 14, 2026, almost exactly matching the loss suffered by the pharmaceutical (pharma) sector, as investors…
How the Performance Marketing Reset Affects the Open Web
This post was created in partnership with Taboola Consumers exhibit different patterns and preferences depending on the industry. Brands need to optimize so they show up in results through chatbots and the open web. As always, when it comes to…
Pressure builds on Jackson to disclose campaign finances in Maine Senate race
Democratic hopeful Troy Jackson is facing pressure to disclose his campaign donors in the Maine Senate race, with early voting now underway in the key midterm battle. While on the campaign trail, Republican candidate and the five-term incumbent…
TotalEnergies future still in the balance as registration deadline looms
The October 15 deadline for teams to make their registration for the 2027 season is approaching fast, but longstanding French ProTeam squad TotalEnergies have yet to issue a definitive statement about the viability of their future for next year.
Contextual Intelligence Is Reshaping How Campaigns Target Audiences
This post was created in partnership with Silverpush Contextual intelligence is a powerful tool for helping brands target media viewers in a new way. During an ADWEEK House Advertising HQ panel co-hosted with Silverpush, Trishla Ostwal, AI and tech…
History Says This Is Hands-Down the Best ETF to Buy if a Bear Market Is Coming
The S&P 500 index (^GSPC -0.02%) has had a better-than-average year, with a total return of about 15% year to date. But many investors worry that a bear market is right around the corner. There are a few big risks facing the stock market. Higher…
Receive a Daily briefing on Pharma Industry News
Get Started